loading
loading

Ameriderm Research

About Us

shape

Our Dermatologic Research Investigators

James A. Solomon, MD, PhD
Director of Research and Principal Investigator

Our director of research, Dr. James Solomon is a Board-Certified Dermatologist who has been performing clinical trials since the 1970s. He has assembled a highly skilled team within Ameriderm Research.
View CV

Sandra Warrington
Clinical Trials Manager/Certified Clinical Research Coordinator

Sandra has been involved in managing clinical trials since 1997.

Dr. Steven Eubanks
Principle/Sub-Investigator

View CV

William Bethea, DO
Sub-Investigator

View CV

Deanna Wallace
Clinical Research Coordinator

Teresa Nicks
Regulatory Specialist and Clinical Research Coordinator

What We Do

Founded in 2006 by Executive Chairman and Founder of Advanced Dermatology Dr. Matt Leavitt, Ameriderm conducts and publishes the results of research studies that advance the practice of dermatology by developing better treatments for patients with dermatologic conditions.

Recently, concerns over the magnitude of COVID-19’s effect on the timely detection and management of melanoma and non-melanoma skin cancers led an elite team of researchers, including Ameriderm’s Director of Research Dr. James Solomon and Dr. Leavitt to participate in research that was published in the Journal of the American Academy of Dermatology (JAAD).

Dr. Solomon and Advanced Dermatology’s Dr. Murray Cotter also participated in a recent study that demonstrated the effectiveness of Total-Body Skin Cancer Exams, which was published in the Journal of Clinical Oncology®, an American Society of Clinical Oncology (ASCO) Journal.

We provide our vast patient population with leading-edge solutions to skin conditions by providing access to new drugs and treatments through pharmaceutical/device company initiated, FDA-supervised clinical trials approved by Institutional Review Boards (IRB).

Our centralized administrative office oversees contracting, provides uniform methodology, assures quality, and provides exemplary data documentation.

The FDA requires that clinical-trial participants are treated with a very high standard of care and that safety is the highest priority. Before the trial, participants can expect to have physical exams, including EKGs and blood work – and they will be monitored very closely throughout the trial by people who report to the FDA.  There is a concentration on each participant’s general health. Tests may reveal health issues they are unaware of. Certain underlying health concerns may be a disqualifier for some clinical trials.

Our Mission

We are committed to providing comprehensive and unparalleled dermatologic clinical research in a welcoming and engaging environment.

Ameriderm Research Clinical Trials

View More

Sponsors and CROs

View More

FAQs

Ameriderm Research participates in FDA-supervised, IRB-approved pharmaceutical and device company sponsored clinical trials in all dermatologic conditions including psoriasis, atopic dermatitis (eczema), rosacea, acne, hidradenitis suppurativa, alopecia, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, melanoma, other skin cancers, warts, as well as cosmetic studies involving lasers, fillers, and neuromuscular agents.

Clinical Trials are conducted under an international agreement of oversight by the US FDA, Canadian FDA and regulatory authorities in Europe and Japan. The agreement focuses on GCP (good clinical practices) which clarify that patient safety takes precedence over testing any new drug or device. These agencies oversee the studies internationally. They approve of the protocol and follow the study from conception to completion.  IRBs (Institutional Review Boards), known as Ethics Boards outside of the US, also approve the design of the study and monitor the studies to confirm safety and other ethical approaches are maintained. The inclusion/exclusion criteria for clinical trials are designed so that those who participate are those in whom participation is appropriately safe and ethical while excluding people for whom participation may not fully meet these criteria. Patients are seen typically more frequently in clinical trials than in clinical practice. At these visits not only is response to treatment assessed, but also ongoing patient safety procedures are performed which may include physical exams, blood tests, and imaging tests.

Participants may have a desire to help develop new and better treatments or want medical attention for a condition that has resisted treatment. Some are unable to afford effective commercially available treatments.

www.clinicaltrials.gov

This website has been established by the FDA through a mandate from the US congress to provide information concerning clinical trials in general as well as the specifics of all clinical trials being conducted in the US.

Complete the contact form or call Sandra Warrington at 386.523.0768.

Please use our contact form and we will get in touch with you.

shape shape
Location

Ameriderm Research
725 W Granada Blvd, Ste 44
Ormond Beach, FL 32174
386.523.0768

Images are loading, please wailt a minute.